For most people with multiple sclerosis (MS), the use of disease-modifying therapies, or DMTs, does not affect their perceived pain, according to a survey-based study in Australia. As few as one-third of MS patients who had ever used DMTs reported a change in pain, while one-eighth of those currently using DMTs reported such a change,…
Category: Multiple Sclerosis Research
Finding Balance: Navigating the Holiday Season with MS
For many people, the holidays are pictured as a “most wonderful time of the year,” filled with parties, gifts, and endless cheer. But for those living with multiple sclerosis (MS), the season often feels different. It can bring a complicated … Continue reading → Source: blog.mymsaa.org
Mediterranean and MIND diets track with cognitive benefits in MS
Adherence to either the Mediterranean or the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diets was associated with better performance in certain areas of thinking and memory among people with multiple sclerosis (MS), a U.K. study suggests. The Mediterranean diet reflects foods traditionally eaten in countries around the Mediterranean Sea. It emphasizes fruits, vegetables, legumes, fish,…
The cost of ADA
Tweet Jamieson T, Tomini F, Gnanapavan S, Mihaylova B. Long-term effectiveness and cost-effectiveness of testing for alemtuzumab antidrug antibodies to guide treatment in multiple sclerosis: a modelling study. Eur J Health Econ. 2025 Nov 12. doi: 10.1007/s10198-025-01854-8 Biologic therapies are increasingly used in multiple sclerosis (MS), but often provoke anti-drug antibodies, potentially leading to treatment…
Water exercise beats standard PT for MS fatigue, balance issues
Aquatic therapy significantly eased fatigue and improved balance in multiple sclerosis (MS) patients in a clinical trial in Greece, outperforming results from a control group who participated in a conventional physiotherapy program. “Our work suggests that incorporating [aquatic therapy] into MS care can meaningfully alleviate fatigue and balance deficits, thereby improving patients’ functional capabilities and…
Welcome December
I am a day late with saying this, but happy December to y’all! Can you believe it is already December? Where has the year gone? It seems the older I get, the faster the years fly by. At this moment, which I know can change at any time, the weather has finally been colder. Mother…
Multiple sclerosis economic burden exceeds $3 billion as prevalence soars in Australia
The post Multiple sclerosis economic burden exceeds $3 billion as prevalence soars in Australia appeared first on MS Australia. Source: www.msaustralia.org.au
Oral bacteria tied to more severe multiple sclerosis symptoms
People with multiple sclerosis (MS) who have higher levels of Fusobacterium nucleatum in the mouth — bacteria that can contribute to periodontitis, a serious gum infection — may be more likely to experience more severe symptoms, according to a study from Japan. This finding adds to recent preclinical evidence suggesting that periodontitis may be associated…
Q&A december
Tweet Have a question this is the place for you Source: multiple-sclerosis-research.org
NEDA Fudge and Alemtuzumab
Tweet No evidence of disease control is typically no relapse no MRI lesions and no progression. Whilst as mentioned I think progtrssion is a composite surrogate of different biologies the question is how good are drugs at inducing NEDA. Here we hear about alemtuzumab and they tell us that the proportion of patients achieving NEDA-3…